Literature DB >> 18998233

A distinctive translocation carcinoma of the kidney ["rosette-like forming," t(6;11), HMB45-positive renal tumor].

Milan Hora1, Ondrej Hes, Tomás Urge, Viktor Eret, Jirí Klecka, Michal Michal.   

Abstract

OBJECTIVE: Recently, a novel renal carcinoma with specific clinical and histological characteristics and translocation t(6;11)(p21.1;q12 or q13) has been identified. We have found 11 cases in the literature, and we are adding another 3 cases.
MATERIALS AND METHODS: Three cases were found in the Plzen pathological register with approximately 15,000 cases of kidney tumors. There were two females and 1 male, aged 22, 24, and 39 years.
RESULTS: The sizes of the tumors were 40, 136, and 10 mm. Two tumors were found incidentally; the biggest one was self-palpated by a 24-year-old pregnant patient. Patients are without any signs of disease 42, 20, and 17 months after surgery.
CONCLUSION: This tumor is a distinctive and rare translocation carcinoma of the kidney [t(6;11), HMB45 positive]. All cases with known clinical data arose in younger people. The malignant potential is probably low.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998233     DOI: 10.1007/s11255-008-9495-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  7 in total

1.  Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints.

Authors:  M van Asseldonk; M Schepens; D de Bruijn; B Janssen; G Merkx; A Geurts van Kessel
Journal:  Genomics       Date:  2000-05-15       Impact factor: 5.736

2.  A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation.

Authors:  P Argani; A Hawkins; C A Griffin; J D Goldstein; M Haas; J B Beckwith; C B Mankinen; E J Perlman
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

Review 3.  A case of renal cancer with TFE3 gene fusion in an elderly man. Clinical, radiological and surgical findings.

Authors:  Aldo Franzini; Stefano Carlo Maria Picozzi; Paolo Luca Politi; Luigi Barana; Fabio Bianchi; Giuseppe Alfano; Giampiera Gatti; Franco Fanciullacci; Massimo Gariboldi; Mirella Strada; Biagio Eugenio Leone
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

4.  Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.

Authors:  Ian J Davis; Bae-Li Hsi; Jason D Arroyo; Sara O Vargas; Y Albert Yeh; Gabriela Motyckova; Patricia Valencia; Antonio R Perez-Atayde; Pedram Argani; Marc Ladanyi; Jonathan A Fletcher; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

5.  Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution.

Authors:  Roland P Kuiper; Marga Schepens; José Thijssen; Martien van Asseldonk; Eva van den Berg; Julia Bridge; Ed Schuuring; Eric F P M Schoenmakers; Ad Geurts van Kessel
Journal:  Hum Mol Genet       Date:  2003-07-15       Impact factor: 6.150

6.  Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.

Authors:  Lorenza Pecciarini; M Giulia Cangi; Crocifissa Lo Cunsolo; Ettore Macri'; Elena Dal Cin; Guido Martignoni; Claudio Doglioni
Journal:  Genes Chromosomes Cancer       Date:  2007-05       Impact factor: 5.006

7.  Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.

Authors:  Pedram Argani; Semra Olgac; Satish K Tickoo; Michael Goldfischer; Holger Moch; David Y Chan; John N Eble; Stephen M Bonsib; Mireya Jimeno; Josep Lloreta; Athanase Billis; Jessica Hicks; Angelo M De Marzo; Victor E Reuter; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2007-08       Impact factor: 6.394

  7 in total
  7 in total

1.  t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.

Authors:  Nathaniel E Smith; Peter B Illei; Mohamed Allaf; Nilda Gonzalez; Kerry Morris; Jessica Hicks; Angelo Demarzo; Victor E Reuter; Mahul B Amin; Jonathan I Epstein; George J Netto; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

2.  TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.

Authors:  Sounak Gupta; Pedram Argani; Achim A Jungbluth; Ying-Bei Chen; Satish K Tickoo; Samson W Fine; Anuradha Gopalan; Hikmat A Al-Ahmadie; Sahussapont J Sirintrapun; Alejandro Sanchez; Abraham Ari Hakimi; Tiffany Mcfarlane; Paulo A Salazar; Sean R Williamson; Stephanie L Skala; Rohit Mehra; Ondrej Hes; Cristina R Antonescu; Marc Ladanyi; Maria E Arcila; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

3.  Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.

Authors:  Qiu Rao; Xiu-Mei Zhang; Pin Tu; Qiu-Yuan Xia; Qin Shen; Xiao-Jun Zhou; Qun-Li Shi
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 4.  Renal cell carcinoma: Evolving and emerging subtypes.

Authors:  Suzanne M Crumley; Mukul Divatia; Luan Truong; Steven Shen; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2013-12-16       Impact factor: 1.337

5.  t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma.

Authors:  Anna Caliò; Matteo Brunelli; Diego Segala; Serena Pedron; Regina Tardanico; Andrea Remo; Stefano Gobbo; Emanuela Meneghelli; Claudio Doglioni; Ondrej Hes; Claudia Zampini; Pedram Argani; Guido Martignoni
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 7.842

Review 6.  Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.

Authors:  Qiu Rao; Qiu-Yuan Xia; Liang Cheng; Xiao-Jun Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

7.  MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)].

Authors:  Milan Hora; Tomáš Urge; Ivan Trávníček; Jiří Ferda; Zdeněk Chudáček; Tomáš Vaněček; Michal Michal; Fredrik Petersson; Naoto Kuroda; Ondřej Hes
Journal:  Springerplus       Date:  2014-05-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.